Showing results (581-590 of 615) with videos related to
Sort By:
Pageof 62
Brain Communications|April 3, 2023
Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutationsMaximilian Wiesenfarth, Kornelia Günther, Kathrin Müller, et al.European Journal of Neurology|March 10, 2023
Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis-a cross-sectional multicenter studyThomas Meyer, Erma Salkic, Torsten Grehl, et al.Muscle & Nerve|July 20, 2024
Clinical and patient-reported outcomes and neurofilament response during tofersen treatment in SOD1-related ALS-A multicenter observational study over 18 monthsThomas Meyer, Peggy Schumann, Patrick Weydt, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 1, 2022
Remote digital assessment of amyotrophic lateral sclerosis functional rating scale - a multicenter observational studyThomas Meyer, Susanne Spittel, Torsten Grehl, et al.Journal of Neurology|December 13, 2025
Motor phenotypes and neurofilament light chain in genetic amyotrophic lateral sclerosis-results from a multicenter screening programPhilipp Schmitt, Peggy Schumann, Alexander Koerbs, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 22, 2025
Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient's smartphone proves to be non-inferior to clinic data captureLaura Steinfurth, Torsten Grehl, Ute Weyen, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 13, 2024
SOD1 gene screening in ALS - frequency of mutations, patients' attitudes to genetic information and transition to tofersen treatment in a multi-center programThomas Meyer, Peggy Schumann, Torsten Grehl, et al.Cancer Cell|June 5, 2003
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative diseaseJan Cools, Elizabeth H Stover, Christina L Boulton, et al.Human Molecular Genetics|September 17, 2018
Nuclear localization and phosphorylation modulate pathological effects of alpha-synucleinRaquel Pinho, Isabel Paiva, Kristina Gotovac Jercic, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 11, 2025
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter studySusanne Spittel, Torsten Grehl, Patrick Weydt, et al.Pageof 62